Martyn R. Thomas

Showing 1-20 of 24 articles

Interventions for valvular disease

Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve

Sawaya F, Kappetein A, Wisser W, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Wimmer-Greinecker G, Serruys P, Lefèvre T

August 20, 2016

Interventions for valvular disease

How should I treat a patient with a mechanical aortic valve prosthesis and recurrent intracranial bleeding on anticoagulation with a patent LIMA to LAD?

Patterson T, Davies W, Rajani R, Redwood S, Young C, Thomas M, Bosmans J, Rodrigus I, Melnitchouk S, Sundt T

June 20, 2016 | 10.4244/EIJV12I3A69

Interventions for valvular disease

Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry

Malkin C, Long W, Baxter P, Gale C, Wendler O, Monaghan M, Thomas M, Ludman P, De Belder M, Cunningham A, Moat N, Blackman D

February 19, 2016 | 10.4244/EIJY14M12_12

Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial

Thomas M, Nienaber C, Naber C, Ince H, Erglis A, Vukcevic V, Schäfer U, Ferreira R, Hardt S, Verheye S, Ribeiro V, Sugeng L, Tamburino C

October 20, 2015 | 10.4244/EIJV11I6A143

Interventions for valvular disease

The Arto transcatheter mitral valve repair system

Erglis A, Thomas M, Morice M, Narbute I, Zabunova M, Hovasse T, Poupineau M, Rudzitis A, Kamzola G, Zvaigzne L, Greene S, Rogers J

September 17, 2015 | 10.4244/EIJV11SWA12

The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis

Khawaja M, Asrress K, Haran H, Arri S, Nadra I, Bolter K, Wilson K, Clack L, Hancock J, Young C, Bapat V, Thomas M, Redwood S

August 20, 2015 | 10.4244/EIJY14M05_09

Early and late changes in quality of life following transcatheter aortic valve implantation using the transfemoral and transapical approaches

Bona V, Khawaja M, Bapat V, Young C, Hancock J, Redwood S, Fusari M, Thomas M

June 19, 2015 | 10.4244/EIJV11I2A41

One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study

Thomas M, Birkemeyer R, Schwimmbeck P, Legrand V, Moreno R, Briguori C, Werner N, Bramucci E, Ungi I, Richardt G, Underwood P, Dawkins K

March 20, 2015 | 10.4244/EIJY15M01_07

Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry

Eggebrecht H, Mehta R, Kahlert P, Schymik G, Lefèvre T, Lange R, Macaya C, Mandinov L, Wendler O, Thomas M

December 22, 2014 | 10.4244/EIJV10I8A165

Coronary artery disease in patients undergoing TAVI - why not to treat

Khawaja M, Redwood S, Thomas M

September 27, 2014 | 10.4244/EIJV10SUA11

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device

Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M

September 27, 2014 | 10.4244/EIJV10SUA18

Welcome to PCR London Valves 2014

Thomas M, Windecker S

September 27, 2014 | 10.4244/EIJV10SUA1

Direct TAVI using a balloon-expandable system: a novel technique to eliminate pre-deployment balloon aortic valvuloplasty

Davies W, Bapat V, Hancock J, Young C, Redwood S, Thomas M

June 20, 2014 | 10.4244/EIJV10I2A40

Welcome to PCR London Valves 2013

Thomas M, Windecker S

September 15, 2013 | 10.4244/EIJV9SSA1

Virtual fractional flow reserve by coronary computed tomography - hope or hype?

Rajani R, Wang Y, Uss A, Perera D, Redwood S, Thomas M, Chambers J, Preston R, Carr-White G, Liatsis P

June 28, 2013 | 10.4244/EIJV9I2A44

Welcome to PCR London Valves 2012

Thomas M, Windecker S

September 30, 2012 | 10.4244/EIJV8SQA1

The effects of VARC-defined acute kidney injury after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis

Khawaja M, Thomas M, Joshi A, Asrress K, Wilson K, Bolter K, Young C, Hancock J, Bapat V, Redwood S

September 28, 2012 | 10.4244/EIJV8I5A87

An interdisciplinary debate initiated by the European Society of Cardiology Working Group on Valvular Heart Disease

Naber C, Prendergast B, Thomas M, Vahanian A, Iung B, Rosenhek R, Tornos P, Otto C, Antunes M, Kappetein A, Lange R, Wendler O

March 21, 2012 | 10.4244/EIJV7I11A201

Complications of transcatheter aortic valve implantation: avoidance and management

Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, MacCarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N

September 30, 2011 | 10.4244/EIJV7I5A99

Transcatheter aortic valve implantation (TAVI): how to interpret the data and what data is required?

Thomas M, Wendler O

May 19, 2009

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.